Cellular oxygen sensing need in CNS function: Physiological and pathological implications

Journal of Experimental Biology

Volumn 207, Issue 18, 2004, Pages 3171-3188

  Acker, Till ^a,b   Acker, Helmut ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Edinger Institute   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Glioblastoma; HIF prolyl hydroxylase; Hypoxia inducible factor; Iron; Ischemia; Mitochondria; Mitochondriopathy; NADPH oxidase; Neurodegenerative disease; Neurogenesis; Oxygen sensing; Preconditioning; Reactive oxygen species; Stem cell; Tumor; VEGF

Indexed keywords

HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR;

ADAPTATION; APOPTOSIS; BLOOD FLOW; BRAIN HYPOXIA; CELL HYPOXIA; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; APOPTOSIS; CELL HYPOXIA; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYPOXIA, BRAIN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 4644259153     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.01075     Document Type: Review

References (186)

1. Aberg, M. A., Aberg, N. D., Hedbacker, H., Oscarsson, J. and Eriksson, P. S. (2000). Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci. 20, 2896-2903.
2. Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Bruck, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K. and Lassmann, H. (2003). Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol 62, 25-33.
3. Acker, H., Lubbers, D. W., Purves, M. J. and Tan, E. D. (1980). Measurements of the partial pressure of oxygen in the carotid body of fetal sheep and newborn lambs. J. Dev. Physiol. 2, 323-328.
4. Acker, T. and Plate, K. H. (2002). A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology. J. Mol. Med. 80, 562-575.
5. Acker, T. and Plate, K. H. (2003). Role of hypoxia in tumor angiogenesis - molecular and cellular angiogenic crosstalk. Cell Tissue Res. 80, 562-575.
6. Althausen, S., Mengesdorf, T., Mies, G., Olah, L., Nairn, A. C., Proud, C. G. and Paschen, W. (2001). Changes in the phosphorylation of initiation factor eIF-2alpha, elongation factor eEF-2 and p70 S6 kinase after transient focal cerebral ischaemia in mice. J. Neurochem. 78, 779-787.
7. Alvarez-Tejado, M., Alfranca, A., Aragones, J., Vara, A., Landazuri, M. O. and del Peso, L. (2002). Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem. 277, 13508-13517.
8. Archer, S. L., Reeve, H. L., Michelakis, E., Puttagunta, L., Waite, R., Nelson, D. P., Dinauer, M. C. and Weir, E. K. (1999). O-2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc. Nail Acad. Sci. USA 96, 7944-7949.
9. Arsham, A. M., Howell, J. J. and Simon, M. C. (2003). A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 278, 29655-29660.
10. Arthur, P. G., Ngo, C. T., Moretta, P. and Guppy, M. (1999). Lack of oxygen sensing by mitochondria in platelets. Eur. J. Biochem. 266, 215-219.
11. Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z. and Lindvall, O. (2002). Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8, 963-970.
12. Astuti, D., Latif, F., Dallol, A., Dahia, P. L., Douglas, F., George, E., Skoldberg, F., Husebye, E. S., Eng, C. and Maher, E. R. (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49-54.
13. Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., van der May, A., Taschner, P. E., Rubinstein, W. S., Myers, E. N. et al. (2000). Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848-851.
14. Beck, H., Acker, T., Wiessner, C., Allegrini, P. R. and Plate, K. H. (2000). Expression of angiopoietin-1, angiopoietin-2, and the receptors after middle cerebral artery occlusion in the rat. Am. J. Pathol. 157, 1473-1483.
15. Bence, N. F., Sampat, R. M. and Kopito, R. R. (2001). Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555.
16. Bergeron, M., Gidday, J. M., Yu, A. Y., Semenza, G. L., Ferriero, D. M. and Sharp, F. R. (2000). Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48, 285-296.
17. Bergeron, M., Yu, A. Y., Solway, K. E., Semenza, G. L. and Sharp, F. R. (1999). Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11, 4159-4170.
18. Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T. and Petit, E. (1999). A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 643-651.
19. Bernaudin, M., Nedelec, A. S., Divoux, D., MacKenzie, E. T., Petit, E. and Schumann-Bard, P. (2002). Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22, 393-403.
20. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D. and Pouyssegur, J. (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 22, 4082-4090.
21. Bickler, P. E., Fahlram, C. S. and Taylor, D. M. (2003). Oxygen sensitivity of NMIDA receptors: Relationship to NR2 subunit composition and hypoxia tolerance of neonatal neurons. Neuroscience 118, 25-35.
22. Bilton, R. L. and Booker, G. W. (2003). The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur. J. Biochem. 270, 791-798.
23. Bishop, G. M., Robinson, S. R., Liu, Q., Perry, G., Atwood, C. S. and Smith, M. A. (2002). Iron: a pathological mediator of Alzheimer disease? Dev. Neurosci. 24, 184-187.
24. Blancher, C., Moore, J. W., Talks, K. L., Houlbrook, S. and Harris, A. L. (2000). Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res. 60, 7106-7113.
25. Blouw B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H. P., Johnson, R. S. and Bergers, G. (2003). The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4, 133-146.
26. Brickley, S. G., Revilla, V., Cull-Candy, S. G., Wisden, W. and Farrant, M. (2001). Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409, 88-92.
27. Bruick, R. K. and McKnight, S. L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
28. Canbolat, O., Fandrey, J. and Jelkmann, W. (1998). Effects of modulators of the production and degradation of hydrogen-peroxide on erythropoietin synthesis. Resp. Physiol. 114, 175-183.
29. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P. et al. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490.
30. Carmeliet, P. and Storkebaum, E. (2002). Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin. Cell Dev. Biol. 13, 39-53.
31. Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H. and Poellinger, L. (2000). Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell Biol. 20, 402-415.
32. Chan, D. A., Sutphin, P. D., Denko, N. C. and Giaccia, A. J. (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277, 40112-40117.
33. Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu C. E., Simon, M. C. and Schumacker, P. T. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95, 11715-11720.
34. 2 sensing. J. Biol. Chem. 275, 25130-25138.
35. Chavez, J. C., Agani, F., Pichiule, P. and LaManna, J. C. (2000). Expression of hypoxia-inducible factor-1 alpha in the brain of rats during chronic hypoxia. J. Appl. Physiol. 89, 1937-1942.
36. Chavez, J. C. and LaManna, J. C. (2003). Hypoxia-inducible factor-1alpha accumulation in the rat brain in response to hypoxia and ischemia is attenuated during aging. Adv. Exp. Med. Biol. 510, 337-341.
37. Chun, Y. S., Choi, E., Kim, T. Y., Kim, M. S. and Park, J. W. (2002). A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene. Biochem. J. 362, 71-79.
38. Cioffi, C. L., Liu, X. Q., Kosinski, P. A., Garay, M. and Bowen, B. R. (2003). Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem. Biophys. Res. Commun. 303, 947-953.
39. Cluskey, S. and Ramsden, D. B. (2001). Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol. Pathol. 54, 386-392.
40. Compernolle, V., Brusselmans, K., Acker, T., Hoet, P., Tjwa, M., Beck, H., Plaisance, S., Dor, Y., Keshet, E., Lupu, F. et al. (2002). Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8, 702-710.
41. O2 sensor protein in the rat carotid body. Biochem. J. 272, 743-747.
42. D'Angelo, G., Duplan, E., Boyer, N., Vigne, P. and Frelin, C. (2003). Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J. Biol. Chem. 278, 38183-38187.
43. del Peso, L., Castellanos, M. C., Temes, E., Martin-Puig, S., Cuevas, Y., Olmos, G. and Landazuri, M. O. (2003). The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278, 48690-48695.
44. Denko, N., Wernke-Dollries, K., Johnson, A. B., Hammond, E., Chiang, C. M. and Barton, M. C. (2003a). Hypoxia actively represses transcription by inducing negative cofactor 2 (Dr1/DrAP1) and blocking preinitiation complex assembly. J. Biol. Chem. 278, 5744-5749.
45. Denko, N. C., Fontana, L. A., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R. and Giaccia, A. J. (2003b). Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22, 5907-5914.
46. Digicaylioglu, M. and Lipton, S. A. (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412, 641-647.
47. Dirnagl, U., Simon, R. P. and Hallenbeck, J. M. (2003). Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248-254.
48. Doetsch, F. (2003). The glial identity of neural stem cells. Nat. Neurosci. 6, 1127-1134.
49. + channels to reactive oxygen species. Proc. Natl Acad. Sci. USA 92, 11796-11800.
50. Elvert, G., Kappel, A., Heidenreich, R., Englmeier, U., Lanz, S., Acker, T., Rauter, M., Plate, K., Sieweke, M., Breier, G. and Flamme, I. (2003). Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J. Biol. Chem. 278, 7520-7530.
51. Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L. and Fujii-Kuriyama, Y. (1999). Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18, 1905-1914.
52. Eng, C., Kiuru, M., Fernandez, M. J. and Aaltonen, L. A. (2003). A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat. Rev. Cancer 3, 193-202.
53. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A. et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
54. Erez, N., Milyavsky, M., Eilam, R., Shats, I., Goldfinger, N. and Rotter, V. (2003). Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1 alpha activation and inhibits tumor growth. Cancer Res. 63, 8777-8783.
55. Fandrey, J., Frede, S., Ehleben, W., Porwol, T., Acker, H. and Jelkmann, W. (1997). Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species. Kidney Int. 51, 492-496.
56. Fandrey, J. and Genius, J. (2000). Reactive oxygen species as regulators of oxygen dependent gene expression. Adv. Exp. Med. Biol. 475, 153-159.
57. + current modulation in wild-type and oxidase-deficient mice. Proc. Natl. Acad. Sci. USA 97, 4374-4379.
58. Görlach, A., Camenisch, G., Kvietikova, I., Vogt, L., Wenger, R. H. and Gassmann, M. (2000). Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. Biochim. Biophys. Acta 1493, 125-134.
59. Görlach, A., Berchner-Pfannschmidt U., Wotzlaw C., Cool R. H., Fandrey, J., Acker, H., Jungermann K. and Kietzmann T. (2003). Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: Involvement of the GTPase Rac1. Thromb. Haem. 89, 926-935.
60. Görlach, A., Brandes, R. P., Bassus, S., Kronemann, N., Kirchmaier, C. M., Busse, R. and Schini-Kerth, V. B. (2000a). Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J. 14, 1518-1528.
61. Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F. and Busse, R. (2000b). A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall [see comments]. Circ. Res. 87, 26-32.
62. Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgard, R., Tora, L., Gassmann, M. and Poellinger, L. (1996). Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell Biol. 16, 5221-5231.
63. Haddad, J. J. and Land, S. C. (2001). A non-hypoxic, ROS-senskive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett. 505, 269-274.
64. Hagen, T., Taylor, C. T., Lam, F. and Moncada, S. (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302, 1975-1978.
65. Halterman, M. W., Miller, C. C. and Federoff, H. J. (1999). Hypoxia-inducible factor-1 alpha mediates hypoxia-induced delayed neuronal death that involves p53. J. Neurosci. 19, 6818-6824.
66. Hata, R., Maeda, K., Hermann, D., Mies, G. and Hossmann, K. A. (2000). Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 20, 306-315.
67. Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y. M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldhani, N. J., Bhattacharya, S., Gleadle, J. M. et al. (2002). Hypoxia inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
68. Hirota, K. and Semenza, G. L. (2001). Rac1 activity is required for the activation of hypoxia-inducible factor 1. J. Biol. Chem. 276, 21166-21172.
69. Hirsilä, M., Koivunen, P., Gunzler, V., Kivirikko, K. I. and Myllyharju, J. (2003). Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor HIF. J. Biol. Chem. 278, 30772-30780.
70. Hochachka, P. W. and Lutz, P. L. (2001). Mechanism, origin, and evolution of anoxia tolerance in animals. Comp. Biochem. Physiol. 130B, 435-459.
71. Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B. and Simon, M. C. (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell Biol. 23, 9361-9374.
72. Huang, L. E., Arany, Z., Livingston, D. M. and Bunn, H. F. (1996). Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271, 32253-32259.
73. Huang, L. E. and Bunn, H. F. (2003). Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 278, 19575-19578.
74. Isaacs, J. S., Jung, Y. J., Mimnaugh, E. G., Martinez, A., Cuttitta, F. and Neckers, L. M. (2002). Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J. Biol. Chem. 277, 29936-29944.
75. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12, 149-162.
76. Jeong, J. W., Bae, M. K., Ahn, M. Y., Kim, S. H., Sohn, T. K., Bae, M. H., Yoo, M. A., Song, E. J., Lee, K. J. and Kim, K. W. (2002). Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111, 709-720.
77. Jiang, C. and Haddad, G. G. (1994). A direct mechanism for sensing low oxygen levels by central neurons. Proc. Natl. Acad. Sci. USA 91, 7198-7201.
78. Jin, K., Mao, X. O., Sun, Y., Xie, L. and Greenberg, D. A. (2002a). Stem cell factor stimulates neurogenesis in vitro and in vivo. J. Clin. Invest. 110, 311-319.
79. Jin, K., Minami, M., Lan, J. Q., Mao, X. O., Batteur, S., Simon, R. P. and Greenberg, D. A. (2001). Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci. USA 98, 4710-4715.
80. Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L. and Greenberg, D. A. (2002b). Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA 99, 11946-11950.
81. Jogi, A., Ora, I., Nilsson, H., Lindeheim, A., Makino, Y., Poellinger, L., Axelson, H. and Pahlman, S. (2002). Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc. Natl. Acad. Sci. USA 99, 7021-7026.
82. Jones, R. D., Hancock, J. T. and Morice, A. H. (2000). NADPH oxidase: a universal oxygen sensor? [Review]. Free Radic. Biol. Med. 29, 416-424.
83. Kannurpatti, S. S., Biswal, B. B. and Hudetz, A. G. (2003). Regional dynamics of the fMRI-BOLD signal response to hypoxia-hypercapnia in the rat brain. J. Magnet. Res. Imag. 17, 641-647.
84. Kazemian, P., Stephenson, R., Yeger, H. and Cutz, E. (2001). Respiratory control in neonatal mice with NADPH oxidase deficiency. Resp. Physiol. 126, 89-101.
85. Kietzmann, T., Knabe, W. and Schmidt-Kastner, R. (2001). Hypoxia and hypoxia-inducible factor modulated gene expression in brain: involvement in neuroprotection and cell death. Eur. Arch. Psych. Clin. Neurosci. 251, 170-178.
86. Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y. et al. (2001). Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7, 437-443.
87. Knowles, H. J., Raval, R. R., Harris, A. L. and Ratcliffe, P. J. (2003). Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63, 1764-1768.
88. Koong, A. C., Chen, E. Y., Mivechi, N. F., Denko, N. C., Stambrook, P. and Giaccia, A. J. (1994). Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54, 5273-5279.
89. Koumenis, C., Naczki, C., Koritzinsky, M., Rastani, S., Dichl, A., Sonenberg, N., Koromilas, A. and Wouters, B. G. (2002). Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell Biol. 22, 7405-7416.
90. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P. and Semenza, G. L. (2003). Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138-1143.
91. Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G. and Livingston, D. M. (2000). Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6, 1335-1340.
92. Lambeth, J. D., Cheng, G., Arnold, R. S. and Edens, W. A. (2000). Novel homologs of gp91phox. Trends Biochem. Sci. 25, 459-461.
93. Lambrechts, D., Storkebaum, E., Morimoto, M., Del Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., Al Chalabi, A. et al. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34, 383-394.
94. Lamszus, K., Laterra, J., Westphal, M. and Rosen, E. M. (1999). Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int. J. Dev. Neurosci. 17, 517-530.
95. Lander, H. M. (1997). An essential role for free-radicals and derived species in signal-transduction. FASEB J. 11, 118-124.
96. Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. and Whitelaw, M. L. (2002). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861.
97. Lando, D., Pongratz, I., Poellinger, L. and Whitelaw, M. L. (2000). A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J. Biol. Chem. 275, 4618-4627.
98. Lang, K. J., Kappel, A. and Goodall, G. J. (2002). Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol. Biol. Cell 13, 1792-1801.
99. Lee, I., Bender, E., Arnold, S. and Kadenbach, B. (2001). New control of mitochondrial membrane potential and ROS formation - a hypothesis. Biol. Chem. 382, 1629-1636.
100. 2 pressures. Pflugers Arch. 359, 81-95.
101. Lieb, M. E., Menzies, K., Moschella, M. C., Ni, R. and Taubman, M. B. (2002). Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell Biol. 80, 421-426.
102. Linke, S., Stojkoski, C., Kewley, R. J., Booker, G. W., Whitelaw, M. L. and Peet, D. J. (2004). Substrate requirements of the oxygen-sensing asparaginyl hydroxylase Factor Inhibiting HIF. J. Biol. Chem. 279, 14871-14878.
103. Liu, J., Solway, K., Messing, R. O. and Sharp, F. R. (1998). Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18, 7768-7778.
104. Liu, Q., Berchner-Pfannschmidt, U., Möller, U., Brecht, M., Wotzlaw, C., Acker, H. and Jungermann, K. (2004). A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl Acad. Sci. USA 101, 4302-4307.
105. Lok, C. N. and Ponka, P. (1999). Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274, 24147-24152.
106. Mabjeesh, N. J., Post, D. E., Willard, M. T., Kaur, B., Van Meir, E. G., Simons, J. W. and Zhong, H. (2002). Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res. 62, 2478-2482.
107. (+) channel TASK-1. EMBO J. 20, 47-54.
108. Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H. and Poellinger, L. (2002). Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J. Biol. Chem. 277, 32405-32408.
109. Marti, H. J., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E. and Risau, W. (2000). Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol 156, 965-976.
110. Martin de la Vega, Burda, J., Nemethova, M., Quevedo, C., Alcazar, A., Martin, M. E., Danielisova, V., Fando, J. L. and Salinas, M. (2001). Possible mechanisms involved in the down-regulation of translation during transient global ischaemia in the rat brain. Biochem. J. 357, 819-826.
111. Martin, M. E., Munoz, F. M., Saunas, M. and Fando, J. L. (2000). Ischaemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells. Biochem. J. 351, 327-334.
112. Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W. and Ratcliffe, P. J. (1997). Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94, 8104-8109.
113. Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J. H., Stolze, I., Klinger, M., Huang, W. Q., Wotzlaw, C., Hellwig-Burgel, T., Jelkmann, W. et al. (2003). Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326.
114. Mills, E. and Jöbsis, F. F. (1972). Mitochondrial respiratory chain of carotid body and chemoreceptor response to changes in oxygen tension. J. Neurophysiol. 35, 405-428.
115. Minet, E., Mottet, D., Michel, G., Roland, I., Raes, M., Remade, J. and Michiels, C. (1999). Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett. 460, 251-256.
116. Morrison, S. J., Csete, M., Groves, A. K., Melega, W., Wold, B. and Anderson, D. J. (2000). Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J. Neurosci. 20, 7370-7376.
117. Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M. and Michiels, C. (2003). Regulation of hypoxia-inducible factor-1 alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/ glycogen synthase kinase 3beta pathway in HepG2 cells. J. Biol. Chem. 278, 31277-31285.
118. Mukhopadhyay, C. K., Mazumder, B. and Fox, P. L. (2000). Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275, 21048-21054.
119. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E. and Zlotnik, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
120. Nakatomi, H., Kuriu, T., Okabe, S., Yamamoto, S., Hatano, O., Kawahara, N., Tamura, A., Kirino, T. and Nakafuku, M. (2002). Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110, 429-441.
121. Niemann, S. and Muller, U. (2000). Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26, 268-270.
122. Noble, M., Smith, J., Power, J. and Mayer-Proschel, M. (2003). Redox state as a central modulator of precursor cell function. Ann. NY Acad. Sci. 991, 251-271.
123. Nordberg, J. and Arner, E. S. (2001). Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31, 1287-1312.
124. Nulton-Persson, A. C. and Szweda, L. I. (2001). Modulation of mitochondrial function by hydrogen peroxide. J. Biol. Chem. 276, 23357-23361.
125. 2-sensing in model airway chemoreceptor cells. Biochem. Biophys. Res. Commun. 283, 1131-1134.
126. 2 sensing by airway chemoreceptor-derived cells. J. Biol. Chem. 275, 7684-7692.
127. Oehme, F., Ellinghaus, P., Kolkhof, P., Smith, T. J., Ramakrishnan, S., Hutter, J., Schramm, M. and Flamme, I. (2002). Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296, 343-349.
128. Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Hellings, P., Gorselink, M., Heymans, S. et al. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28, 131-138.
129. Park, S. K., Dadak, A. M., Haase, V. H., Fontana, L., Giaccia, A. J. and Johnson, R. S. (2003). Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol. Cell Biol. 23, 4959-4971.
130. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S. and Comoglio, P. M. (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361.
131. Piret, J. P., Mottet, D., Raes, M. and Michiels, C. (2002). Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem. Pharmacol. 64, 889-892.
132. Porwol, T., Ehleben, W., Brand, V. and Acker, H. (2001). Tissue oxygen sensor function of NADPH oxidase isoforms, an unusual cytochrome aa3 and reactive oxygen species. Respir. Physiol 128, 331-348.
133. Prass, K., Ruscher, K., Karsch, M., Isaev, N., Megow, D., Priller, J., Scharff, A., Dirnagl, U. and Meisel, A. (2002). Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22, 520-525.
134. Prass, K., Scharff, A., Ruscher, K., Lowl, D., Muselmann, C., Victorov, I., Kapinya, K., Dirnagl, U. and Meisel, A. (2003). Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34, 1981-1986.
135. Rakhit, R., Cunningham, P., Furtos-Matei, A., Dahan, S., Qi, X. F., Crow, J. P., Cashman, N. R., Kondejewski, L. H. and Chakrabartty, A. (2002). Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 277, 47551-47556.
136. Richard, D. E., Berra, E. and Pouyssegur, J. (2000). Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275, 26765-26771.
137. Rolfs, A., Kvietikova, I., Gassmann, M. and Wenger, R. H. (1997). Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272, 20055-20062.
138. 2+](i) and respiratory responses to hypoxia. Brain Res. 872, 188-193.
139. Ryan, H. E., Lo, J. and Johnson, R. S. (1998). HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005-3015.
140. Salceda, S. and Caro, J. (1997). Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol Chem. 272, 22642-22647.
141. Sanders, K. A., Sundar, K. M., He, L., Dinger, B., Fidone, S. and Hoidal, J. R. (2002). Role of components of the phagocytic NADPH oxidase in oxygen sensing. J. Appl. Physiol. 93, 1357-1364.
142. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., Mantovani, A., Melillo, G. and Sica, A. (2003). Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
143. Schipani, E., Ryan, H. E., Didrickson, S., Kobayashi, T., Knight, M. and Johnson, R. S. (2001). Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15, 2865-2876.
144. Seagroves, T. N., Hadsell, D., McManaman, J., Palmer, C., Liao, D., McNulty, W., Welm, B., Wagner, K. U., Neville, M. and Johnson, R. S. (2003). HIF1alpha is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 130, 1713-1724.
145. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
146. Shingo, T., Sorokan, S. T., Shimazaki, T. and Weiss, S. (2001). Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21, 9733-9743.
147. Soucek, T., Cumming, R., Dargusch, R., Maher, P. and Schubert, D. (2003). The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39, 43-56.
148. Sowter, H. M., Raval, R., Moore, J., Ratcliffe, P. J. and Harris, A. L.
149. Srinivas, V., Leshchinsky, I., Sang, N., King, M. P., Minchenko, A. and Caro, J. (2001). Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J. Biol. Chem. 276, 21995-21998.
150. Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J. and Krek, W. (2003). Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425, 307-311.
151. Storkebaum, E. and Carmeliet, P. (2004). VEGF: a critical player in neurodegeneration. J. Clin. Invest 113, 14-18.
152. O2 affinity correlates as putative oxygen sensor with rat carotid body chemoreceptor discharge. FASEB J. 16, 1277-1279.
153. Stroka, D. M., Burkhardt, T., Desbaillets, I., Wenger, R. H., Neil, D. A., Bauer, C., Gassmann, M. and Candinas, D. (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 15, 2445-2453.
154. Studer, L., Csete, M., Lee, S. H., Kabbani, N., Walikonis, J., Wold, B. and McKay, R. (2000). Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20, 7377-7383.
155. Sullivan, J. M., Alousi, S. S., Hikade, K. R., Bahn, N. J., Rafols, J. A., Krause, G. S. and White, B. C. (1999). Insulin induces dephosphorylation of eukaryotic initiation factor 2alpha and restores protein synthesis in vulnerable hippocampal neurons after transient brain ischemia. J. Cereb. Blood Flow Metab. 19, 1010-1019.
156. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. and Greenberg, D. A. (2003). VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111, 1843-1851.
157. Tabata, M., Tarumoto, T., Ohmine, K., Furukawa, Y., Hatake, K., Ozawa, K., Hasegawa, Y., Mukai, H., Yamamoto, M. and Imagawa, S. (2001). Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression. J. Cell. Physiol. 186, 260-267.
158. Tacchini, L., Bianchi, L., Bernelli-Zazzera, A. and Cairo, G. (1999). Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142-24146.
159. Takagi, Y., Nozaki, K., Takahashi, J., Yodoi, J., Ishikawa, M. and Hashimoto, N. (1999). Proliferation of neuronal precursor cells in the dentate gyrus is accelerated after transient forebrain ischemia in mice. Brain Res. 831, 283-287.
160. Taylor, J. P., Hardy, J. and Fischbeck, K. H. (2002). Toxic proteins in neurodegenerative disease. Science 296, 1991-1995.
161. Thompson, J. K., Peterson, M. R. and Freeman, R. D. (2003). Single-neuron activity and tissue oxygenation in the cerebral cortex. Science 299, 1070-1072.
162. Thrash-Bingham, C. A. and Tartof, K. D. (1999). aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J. Natl. Cancer Inst. 91, 143-151.
163. Tomlinson, I. P., Alam, N. A., Rowan, A. J., Barclay, E., Jaeger, E. E., Kelsell, D., Leigh, I., German, P., Lamlum, H., Rahman, S. et al. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 30, 406-410.
164. Uchida, T., Rossignol, F., Matthay, M. A., Mounier, R., Couette, S., Clottes, E. and Clerici, C. (2004). Prolonged hypoxia differentially regulates HIF-1 alpha AND HIF-2alpha expression in lung epithelial cells: Implication of HIF-1 alpha natural antisense. J. Biol. Chem. 279, 14871-14878.
165. Unruh, A., Ressel, A., Mohamed, H. G., Johnson, R. S., Nadrowitz, R., Richter, E., Katschinski, D. M. and Wenger, R. H. (2003). The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 22, 3213-3220.
166. Vaux, E. C., Metzen, E., Yeates, K. M. and Ratcliffe, P. J. (2001). Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 98, 296-302.
167. Wang, G. L., Jiang, B. H. and Semenza, G. L. (1995a). Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 212, 550-556.
168. Wang, G. L., Jiang, B. H. and Semenza, G. L. (1995b). Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216, 669-675.
169. Wang, G. L. and Semenza, G. L. (1995). Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237.
170. Wartenberg, M., Ling, F. C., Muschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Putz, V., Hescheler, J. and Sauer, H. (2003). Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J. 17, 503-505.
171. Weissmann, N., Tadic, A., Hanze, J., Rose, F., Winterhalder, S., Nollen, M., Schermuly, R. T., Ghofrani, H. A., Seeger, W. and Grimminger, F. (2000). Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase- derived H(2)O(2)? [In Process Citation]. Am. J. Physiol. 279, L683-L690.
172. Welsh, S. J., Bellamy, W. T., Briehl, M. M. and Powis, G. (2002). The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62, 5089-5095.
173. 2-regulated gene expression. FASEB J. 16, 1151-1162.
174. Wick, A., Wick, W., Waltenberger, J., Weller, M., Dichgans, J. and Schulz, J. B. (2002). Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 22, 6401-6407.
175. Wiener, C. M., Booth, G. and Semenza, G. L. (1996). In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 225, 485-488.
176. Wiesener, M. S., Jurgensen, J. S., Rosenberger, C., Scholze, C. K., Horstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A., Pugh, C. W. et al. (2003). Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 17, 271-273.
177. Wiesener, M. S., Turley, H., Allen, W. E., Willam, C., Eckardt, K. U., Talks, K. L., Wood, S. M., Gatter, K. C., Harris, A. L., Pugh, C. W., Ratcliffe, P. J. and Maxwell, P. H. (1998). Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92, 2260-2268.
178. 3 of the mitochondrial respiratory chain. FEBS Lett. 351, 370-374.
179. Wong, P. C., Cai, H., Borchelt, D. R. and Price, D. L. (2002). Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5, 633-639.
180. Yan, S. F., Lu, J., Zou, Y. S., Soh-Won, J., Cohen, D. M., Buttrick, P. M., Cooper, D. R., Steinberg, S. F., Mackman, N., Pinsky, D. J. and Stern, D. M. (1999). Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem. 274, 15030-15040.
181. Zagzag, D., Nomura, M., Friedlander, D. R., Blanco, C. Y., Gagner, J. P., Nomura, N. and Newcomb, E. W. (2003). Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. J. Cell Physiol. 196, 394-402.
182. Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W. and Semenza, G. L. (2000). Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88, 2606-2618.
183. Zhang, S. X., Gozal, D., Sachleben, L. R., Jr, Rane, M., Klein, J. B. and Gozal, E. (2003). Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells. FASEB J. 17, 1709-1711.
184. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W. and Semenza, G. L. (2000). Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545.
185. Zhou, J., Schmid, T., Frank, R. and Brune, B. (2004). PI3K/Akt is required for heat shock proteins to protect HIF-1alpha from pVHL-independent degradation. J. Biol. Chem. 279, 13506-13513.
186. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B. et al. (2000). Loss of PTEN facilitates HIF-1-mediated gene expression. Genet. Dev. 14, 391-396.